Background and Purpose: Acute cerebral ischaemia is frequently associated with
Introduction
Ischaemic strokes are associated with headache in over a quarter of cases. [1] [2] [3] [4] [5] This might be due to stimulation of sensory afferents of the trigeminovascular system, either directly by ischaemia or indirectly by cortical spreading depression (SD) secondary to cerebral ischaemia. [6] [7] [8] In rare cases, headache may reflect migrainous stroke. 9, 10 Alternatively, it has been estimated that up to 30% of patients with a presumed transient ischaemic attack (TIA) in fact had a migraine attack with headache and neurological aura symptoms. [11] [12] [13] It is thus conceivable that distinct pathophysiological mechanisms are, at least partly, involved in cerebral ischaemic events with and without associated headache. If true, there might also be a different prognosis for recurring vascular events. 14 Here we compared, in a large cohort of patients with established TIA or minor ischaemic stroke, the long-term risk of recurrent vascular events in patients with and without associated headache.
Methods

Patients and study design
For this study we used data of 2473 participants who were included in the LiLAC (Life Long
After Cerebral ischaemia) cohort, which is based on the Dutch TIA Trial (DTT) that started in 1986. The background, design, and results of this multicenter trial have been described in detail elsewhere. 15 In brief, participants with a TIA (symptoms for less than 24 hours) or minor ischaemic stroke (symptoms for more than 24 hours) and who were still independent in most daily activities (modified Rankin scale <= 3), were, within three months from onset, randomly assigned to 30 mg or 283 mg of aspirin, or 50 mg of atenolol or its placebo, in a factorial design. Participants with a cardiac source of embolism or a clotting disorder were excluded. In the LiLAC study, follow-up of all the participants who were still alive at the end of the DTT (spring 1990) was extended up to the period between March 2001 and December
2003
. 16 For logistical reasons only patients from the 24 hospitals which had enrolled at least 50 patients in the DTT were included in LiLAC (2473 of the original 3150). Follow-up data were obtained from the neurologists who had included patients in the DTT and the patients' general practitioner. If data were still incomplete, the participant (or, if unavailable, a relative or acquaintance) was contacted directly. All the participants were informed about the background and procedures of the trial, both through discussion and by means of a printed information sheet, and all gave their explicit consent. The protocol of the LiLAC study was approved by the ethics committee of the University Medical Centre Utrecht.
Baseline characteristics
Extensive baseline characteristics were recorded in the DTT by neurologists using a checklist that was specifically worded to be understood by patients. The list contained several multiplechoice questions about the nature and time course of symptoms, including the presence and onset of any kind of headache, and whether the headache was throbbing or continuous.
Because the primary aim of the DTT was to assess treatment effects of aspirin and atenolol, no other headache details, nor the presence of associated (migraine) symptoms were recorded. Headache was taken as any headache reported by the patient occurring simultaneous with the onset of TIA or minor stroke. 17 Apart from the specific history, records 
Outcome event
Our primary outcome measure was the composite event of death from all vascular causes, non-fatal stroke (caused by ischaemia or haemorrhage) or non-fatal myocardial infarction, whichever occurred first. Separate analyses were performed for the outcomes cardiac events (fatal or non-fatal myocardial infarction, death from congestive heart failure and sudden death), cerebral events (fatal or non-fatal ischaemic or haemorrhagic stroke) and deaths.
Deaths were furthermore classified as vascular or non-vascular deaths. The definition of vascular death included sudden death (unexpected cardiac death within an hour of onset of symptoms, or within 24 hours if the patient was unexpectedly found dead), or death from stroke, myocardial infarction, congestive heart failure, or systemic bleeding. All events were classified independently by three physicians specialized in the field of cerebrovascular disease according to criteria described previously.
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Statistical analysis
Median follow-up was calculated using the estimates of the censoring distribution as described previously. 18 The occurrence of outcome events in patients with onset headache and those without onset headache was compared in terms of hazard ratios (HRs). HRs were determined with the cause-specific Cox proportional hazards model, with corresponding 95%
confidence intervals (CI), and adjusted in bivariable analyses for differences in baseline characteristics between patients with or without headache. A final multivariable model was built, which included all variables that changed the crude HR by at least 5% in the bi-variable analyses. Pre-specified subgroups analyses were performed for the primary outcome, and a forest plot of adjusted HRs was drawn. For a visual comparison of the two groups, nonparametric cumulative incidence functions were drawn. 19 They are a crude representation of the data and show the competing risks of death, cardiovascular and cerebral event over time. Cumulative incidence ratios (CIRs) of cardiac events to cerebral events were calculated from these functions with corresponding bootstrap 95% CI. Differences in CIRs between the two groups were tested at various times (5, 10 and 15 years of follow-up) by means of a permutation test. Significance level was set at p<0.05. 
Results
Headache was recorded in 420/2473 (17%) participants. Baseline characteristics and CT findings of the headache and non-headache groups are summarized in Tables 1 and 2 . Followup was complete for all participants until close-out of the DTT. After that, 26 patients were lost to follow-up. In a separate analysis, we assessed which of the demographic or clinical characteristics implied a particularly reduced risk of vascular events. Patients presenting with headache and vertebro-basilar syndrome (HR 0.68; 95% CI 0.45-1.04), aphasia (HR 0.72; 95% CI 0.50-1.03) or visual disturbances only (HR 0.68; 95% CI 0.30-1.51) were found to have the lowest risk (Figure 2 ), but hazard ratios did not differ in a statistically significant way between subgroups.
Discussion
We found that participants in whom a TIA or minor ischaemic stroke was associated with headache had a reduced long-term risk of recurrent vascular events compared with those without headache. This effect seems mainly due to a reduced risk of vascular death. Besides the lower risk of vascular death, our results also suggested a lower risk of cardiac events in participants with headache, whereas the risk of cerebral events seemed comparable to participants without headache. This different trend in cardiac events opposed to cerebral events, however, was not statistically significant.
Our study is the first comparing the long-term vascular prognosis of ischaemic stroke with and without concomitant headache. Onset headache was present in 17% of our population, more frequent among women, and more often associated with lesions involving the cortical and posterior circulation, as reported in other studies. 17, 20 Previous studies that focused on short-term outcome found no relationship between concomitant headache and stroke severity, in hospital mortality and 6 months outcome. 21, 22 The long duration of follow-up, the large number of participants and the large number of outcome events enabled us to adjust for several covariates. The hazard ratio for first vascular event remained statistically significant after adjustment for potential confounders.
The present study also has limitations. Detailed headache profiles, such as history of migraine, severity or location, were not recorded. Therefore we could not relate these characteristics to the outcomes. In addition, the selection of participants was restricted to noncardio embolic TIA or minor stroke. The exclusion of large infarcts reduces the bias related to survival in the acute phase but could also limit the generalizability of the findings.
The Dutch TIA Trial was performed before the TOAST criteria were published, and no formal classification of stroke source was recorded. In the trial, patients with cerebral ischaemia due to identifiable causes other than arterial thrombosis or arterial embolism, including atrial fibrillation, were excluded and therefore, the participants of our study have cerebral ischaemia of presumed arterial origin. We cannot exclude, however, that some of our participants had a cryptogenic source of stroke which in some studies is related to a different outcome than other subtypes of stroke. 23, 24 It is unlikely that the lower vascular event rate in the participants with headache is caused by a higher number of TIA mimics in this group, because there were no differences in hazard ratios between participants presenting with a TIA or a minor ischaemic stroke and participants with or without ischaemic lesions on the CT scan ( Figure 2 ).
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The more benign long-term vascular prognosis in patients with headache points to a possible different pathophysiology of the presenting TIA or minor stroke. Certain subtypes of stroke, including arterial dissections and the reversible cerebral vasoconstriction syndrome (RCVS), present more often with headache than others and are also associated with better long term prognosis after the event. 23, 26 Although arterial dissection and RCVS are relative rare causes of ischaemic stroke, we cannot exclude that they have played a role in our results.
It has been proposed that headache related to stroke is due to stimulation of sensory afferents of the trigeminovascular system. 8 The stimulation could be either directly by ischaemia or indirectly by factors associated with ischaemia. One factor that might play a role in the indirect stimulation of the trigeminovascular system is cortical spreading depression (SD). 7 SD is the likely mechanism for migraine aura and is characterized by slowly spreading waves of neuronal depolarization and associated changes in cerebral blood flow. 27 SD is related to stroke in different ways. First, it may increase susceptibility to stroke. Transgenic mice harboring the human familial hemiplegic migraine type 1 CACNA1A calcium channel gene mutation are highly susceptible to SD and have increased sensitivity to ischaemia, predisposing them to strokes during mild ischaemic events. 28, 29 Second, SD was found in the penumbra of non migrainous patients with middle cerebral artery infarction increasing the infarct lesion size. 30 It is unknown whether the occurrence of SD depends on subtype or cause of stroke and whether this has influence on the long-term prognosis of stroke patients. 31 Headache could be a marker of the presence of SD, even in patients without a history of migraine.
Blood pressure is another factor that is involved in the pathophysiology of stroke related headache. It was previously reported that one of the independent predictors of headache in patients with stroke is the absence of a history of hypertension. 32 This was also confirmed in our cohort and could suggest that atherosclerosis plays a less important role in the pathogenesis of stroke with headache.
We hypothesize that ischaemic stroke with concomitant headache reflects a different subtype of stroke compared to stroke related to other mechanisms, such as atherosclerosis. Future studies are required to confirm this.
